A Study to Assess Long-term Outcomes of Myocarditis Following Administration of COVID-19 mRNA Vaccine (SPIKEVAX)
Conditions: Myocarditis Sponsors: ModernaTX, Inc. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
Immunogenicity After COVID-19 Vaccines in Adapted Schedules
Conditions: Coronavirus Disease 2019; COVID-19 Interventions: Drug: BNT162b2 30 µg; Drug: BNT162b2 20µg; Drug: BNT162b2 6µg; Drug: mRNA-1273 100µg; Drug: mRNA-1273 50µg; Drug: ChAdOx1-S [Recombinant] Sponsors: Universiteit Antwerpen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
Conditions: Influenza; COVID-19 Interventions: Biological: Influenza and COVID-19 Combination A; Biological: Licensed influenza vaccine; Biological: COVID-19 Vaccine; Biological: Influenza and COVID-19 Combination B; Biological: Placebo Sponsors: BioNTech SE; Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2023 Category: Research Source Type: clinical trials
A Phase 3 Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of Booster Vaccination With Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) (WSK-V102D).
Conditions: COVID-19 Interventions: Biological: Recombinant COVID-19 (XBB) Trimer Protein Vaccine (Sf9 Cell) (WSK-V102D); Biological: Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102); Biological: Placebo Sponsors: WestVac Biopharma Co., Ltd.; WestVac Biopharma (Guangzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 19, 2023 Category: Research Source Type: clinical trials
A Phase 1 Trial of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination
Conditions: SARS-CoV-2; COVID-19 Vaccine Interventions: Biological: 30 μg dose of LYB002V14; Biological: 60μg dose of LYB002V14; Biological: placebo Sponsors: Guangzhou Patronus Biotech Co., Ltd.; Yantai Patronus Biotech Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
COVID-19 Vaccine Effectiveness Against Recurrent Infection Among Lung Cancer Patients and Biomarker Research
Conditions: COVID-19 Recurrent; Lung Cancer; Vaccination; Antibody; Chemotherapy; Immune Checkpoint Inhibitor Interventions: Biological: Any Chinese government-recommended COVID-19 booster vaccine Sponsors: Peking Union Medical College Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
Conditions: COVID-19; Coronavirus Disease 2019; Influenza Interventions: Biological: COVID-19 Vaccine Sponsors: Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
Severe Acute Respiratory Syndrome Coronavirus 2 Re-Infection Risk and Vaccine Efficacy in Austria
Conditions: COVID-19 Interventions: Biological: Vaccination against SARS-CoV-2 Sponsors: Medical University of Graz; AGES; Medical University Innsbruck; Austrian Science Fund (FWF) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
COVID-19 Personal Protective Equipment for Vaccinated Health Workers and Convalescents
Conditions: Covid19 Interventions: Other: Personal Protective Equipment Sponsors: University Medical Centre Ljubljana Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Community Care Intervention to Decrease COVID-19 Vaccination Inequities
Conditions: COVID-19 Vaccination Interventions: Behavioral: Community Health Worker Intervention to Enhance Vaccination Behavior (CHW-VB) Sponsors: RAND; Clinical Directors Network; National Institute on Minority Health and Health Disparities (NIMHD) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
PROmotion of COVID-19 BOOSTer VA(X)Ccination in the Emergency Department - PROBOOSTVAXED
Conditions: COVID-19 Interventions: Behavioral: Vaccine Messaging; Behavioral: Vaccine Acceptance Question Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID); Pfizer; Duke University; Baylor College of Medicine; Thomas Jefferson University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Multilevel Intervention of COVID-19 Vaccine Uptake Among Latinos
Conditions: Vaccine Hesitancy Interventions: Behavioral: Multilevel Intervention Sponsors: San Diego State University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 5, 2023 Category: Research Source Type: clinical trials
Characterization of COVID-19 vaccine clinical trial discussions on the social question-and-answer site Quora
ConclusionsOur study found active user discussions related to COVID-19 vaccine clinical trials on Quora, including those specific to minority health topics and those posted by a smaller group of self-identified racial and ethnic minority online users. Results from this study can help identify barriers to participation among the general public and underrepresented groups while also supporting the design of future outreach strategies to help with recruitment and inclusive trial participation. (Source: Trials)
Source: Trials - December 5, 2023 Category: Research Source Type: clinical trials
A Randomized Trial Evaluating a mRNA VLP Vaccine's Immunogenicity and Safety for COVID-19
Conditions: COVID-19; SARS-CoV-2 Infection Interventions: Biological: AZD9838; Biological: Licensed mRNA vaccine Sponsors: AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
Effect of Metformin in Reducing Fatigue in Long COVID in Adolescents
Conditions: Long COVID Interventions: Drug: Metformin; Other: Placebo Sponsors: Trust for Vaccines and Immunization, Pakistan Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 27, 2023 Category: Research Source Type: clinical trials
